Tharimmune, Inc.

General ticker "THAR" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $4.9M (TTM average)

Tharimmune, Inc. follows the US Stock Market performance with the rate: 31.7%.

Estimated limits based on current volatility of 4.2%: low 2.26$, high 2.46$

Factors to consider:

  • Total employees count: 2 as of 2024
  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.21$, 4.10$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.09$, 3.69$]

Financial Metrics affecting the THAR estimates:

  • Positive: with PPE of -0.2 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -403.04 <= 0.33
  • Positive: 18.93 < Shareholder equity ratio, % of 35.14 <= 41.86
  • Negative: negative Industry operating cash flow (median)
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: negative Net income

Similar symbols

Short-term THAR quotes

Long-term THAR plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $6.88MM $9.46MM $12.43MM
Operating Income $-6.88MM $-9.46MM $-12.43MM
Non-Operating Income $-1.59MM $0.14MM $0.24MM
Interest Expense $1.59MM $0.02MM $0.01MM
R&D Expense $2.28MM $3.56MM $6.39MM
Income(Loss) $-8.47MM $-9.32MM $-12.20MM
Profit(Loss)* $-8.47MM $-9.32MM $-12.20MM
Stockholders Equity $5.54MM $9.13MM $1.31MM
Assets $6.69MM $10.95MM $3.72MM
Operating Cash Flow $-6.56MM $-7.30MM $-10.90MM
Financing Cash Flow $13.06MM $11.72MM $3.53MM
Earnings Per Share** $-280.77 $-107.08 $-9.41

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.